Myobloc
Active Ingredient(s): Botulinum Toxin Type BFDA Approved: * December 8, 2000
Pharm Company: * ELAN PHARM
Category: Neurological Disorders
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Myobloc Overview
Botulinum toxin (Botox) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species.[1] It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction, thus causing flaccid paralysis.[2] Infection with the bacterium causes the disease botulism. The toxin is also used commercially for medical and cosmetic purposes. The seven main types of botulinum toxin are named types A to G. New ty...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Botulinum_toxin
Recent Myobloc Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Botulinum Toxin Type B
- Injection: 10000unit/2ml, 2500unit/0.5ml, 5000unit/ml
- Vial: 5000iu/vial
NDC Database Records for Myobloc: (3 results)
Sorted by National Drug Code- 10454-710 Myobloc 2500 [usp'u]/.5ml Intramuscular Injection, Solution by Solstice Neurosciences, LLC
- 10454-711 Myobloc 5000 [usp'u]/Ml Intramuscular Injection, Solution by Solstice Neurosciences, LLC
- 10454-712 Myobloc 10000 [usp'u]/2ml Intramuscular Injection, Solution by Solstice Neurosciences, LLC